Synopsis
Synopsis
0
USDMF
 
																							0
CEP/COS
 
																							0
JDMF
 
																							0
EU WC
 
																							0
KDMF
 
																							0
VMF
 
																							0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
 
																							0
Canada
 
																							0
Australia
 
																							0
South Africa
 
																							
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid 
NA
Annual Reports 
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Ginger Rhizome
2. Ginger Root
3. Rhizoma Zingiberis
4. Rhizoma Zingiberis Recens
5. Zingiberis Rhizoma
6. Zingiberis Rhizoma Praeparatum
7. Zingiberis Siccatum Rhizoma
1. 84696-15-1
2. (e)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one;1-(4-hydroxy-3-methoxyphenyl)-5-methyldecan-3-one
| Molecular Weight | 568.8 g/mol | 
|---|---|
| Molecular Formula | C35H52O6 | 
| Hydrogen Bond Donor Count | 2 | 
| Hydrogen Bond Acceptor Count | 6 | 
| Rotatable Bond Count | 19 | 
| Exact Mass | 568.37638937 g/mol | 
| Monoisotopic Mass | 568.37638937 g/mol | 
| Topological Polar Surface Area | 93.1 Ų | 
| Heavy Atom Count | 41 | 
| Formal Charge | 0 | 
| Complexity | 589 | 
| Isotope Atom Count | 0 | 
| Defined Atom Stereocenter Count | 0 | 
| Undefined Atom Stereocenter Count | 1 | 
| Defined Bond Stereocenter Count | 1 | 
| Undefined Bond Stereocenter Count | 0 | 
| Covalently Bonded Unit Count | 2 | 

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) | Average Price (USD/KGS) | Number of Transactions | 
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Bacillus coagulans MY01 is a Probiotic drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Dyspepsia.
Lead Product(s): Bacillus coagulans MY01,Bacillus subtilis MY02,Ginger extract
Therapeutic Area: Gastroenterology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Probiotic
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 08, 2025

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bacillus coagulans MY01,Bacillus subtilis MY02,Ginger extract
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Probiotic and Ginger Supplement for Symptoms and Quality of Life in Functional Dyspepsia (SUBTILE)
Details : Bacillus coagulans MY01 is a Probiotic drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Dyspepsia.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
October 08, 2025

Details:
Oleoylethanolamide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.
Lead Product(s): Oleoylethanolamide,Ginger extract,Lavender Essential Oil
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Miscellaneous
Sponsor: Nicole Stevens, PhD
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 17, 2025

 
										 
										Lead Product(s) : Oleoylethanolamide,Ginger extract,Lavender Essential Oil
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Nicole Stevens, PhD
Deal Size : Inapplicable
Deal Type : Inapplicable
Metabolic and Epigenetic Impact of FAAH Inhibitors and OEA
Details : Oleoylethanolamide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 17, 2025

Details:
Ginger Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cardiovascular Diseases.
Lead Product(s): Ginger extract,Glycyrrhiza Uralensis Extract,Alternanthera Sessilis Extract,Panax Notoginseng Extract,Red Date Extract,Codonopsis Pilosula Extract,Ligusticum Chuanxiong Extract,Astragalus Membranaceus Extract
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Plant Extract/Herbal
Sponsor: UCSI University
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 02, 2025

 
										 
										Lead Product(s) : Ginger extract,Glycyrrhiza Uralensis Extract,Alternanthera Sessilis Extract,Panax Notoginseng Extract,Red Date Extract,Codonopsis Pilosula Extract,Ligusticum Chuanxiong Extract,Astragalus Membranaceus Extract
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : UCSI University
Deal Size : Inapplicable
Deal Type : Inapplicable
Perfect Heartio Drink and Cardiovascular Health
Details : Ginger Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cardiovascular Diseases.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 02, 2025

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
ARTOVID-20™ (ashwagandha root extract) is a proprietary oral dietary supplement that helps boost immunity. It may help reduce the duration of illness and severity of symptoms reagrding Covid-19 infection.
Lead Product(s): Ashwagandha Root Extract,Ginger extract,Turmeric Root Extract
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Plant Extract/Herbal
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 25, 2023

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ashwagandha Root Extract,Ginger extract,Turmeric Root Extract
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioved Pharmaceuticals Granted a US Patent for Its Oral, Natural Plant-Based Product, Artovid-20®...
Details : ARTOVID-20™ (ashwagandha root extract) is a proprietary oral dietary supplement that helps boost immunity. It may help reduce the duration of illness and severity of symptoms reagrding Covid-19 infection.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
April 25, 2023

 FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
16 Oct 2021
Reply
21 Jan 2021
 FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]		
ABOUT THIS PAGE
81
PharmaCompass offers a list of Ginger extract API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ginger extract manufacturer or Ginger extract supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ginger extract manufacturer or Ginger extract supplier.
PharmaCompass also assists you with knowing the Ginger extract API Price utilized in the formulation of products. Ginger extract API Price is not always fixed or binding as the Ginger extract Price is obtained through a variety of data sources. The Ginger extract Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ginger extract manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ginger extract, including repackagers and relabelers. The FDA regulates Ginger extract manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ginger extract API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ginger extract manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ginger extract supplier is an individual or a company that provides Ginger extract active pharmaceutical ingredient (API) or Ginger extract finished formulations upon request. The Ginger extract suppliers may include Ginger extract API manufacturers, exporters, distributors and traders.
click here to find a list of Ginger extract suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ginger extract as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ginger extract API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ginger extract as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ginger extract and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ginger extract NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ginger extract suppliers with NDC on PharmaCompass.
Ginger extract Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ginger extract GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ginger extract GMP manufacturer or Ginger extract GMP API supplier for your needs.
A Ginger extract CoA (Certificate of Analysis) is a formal document that attests to Ginger extract's compliance with Ginger extract specifications and serves as a tool for batch-level quality control.
Ginger extract CoA mostly includes findings from lab analyses of a specific batch. For each Ginger extract CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ginger extract may be tested according to a variety of international standards, such as European Pharmacopoeia (Ginger extract EP), Ginger extract JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ginger extract USP).
